MYD88 and neoplasm: Their findings revealed that MyD88 promotes the recruitment and activation of various immune cells, including M1-like tumour-associated macrophages, neutrophils, dendritic cells, CD4+ and CD8+ T cells, NK cells, and NKT cells, within the tumour microenvironment [99].